Evidence map›Paper›PMID 22311273›Full record

ArticleMolecular biotechnology2013

A dual-mode single-molecule fluorescence assay for the detection of expanded CGG repeats in Fragile X syndrome.

Brian Cannon, Cynthia Pan, Liangjing Chen, Andrew G Hadd, Rick Russell

Open access · greenAbstract read
In one paragraph

Article in Molecular biotechnology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Brian CannonDepartment of Chemistry and Biochemistry and the Institute for Cellular and Molecular Biology, The University of Texas, 1 University Station A4800, Austin, TX 78712, USA.
Cynthia Pan
Liangjing Chen
Andrew G Hadd
Rick Russell
The University of Texas at Austin · USAsuragen (United States) · US

Funding

Physical and functional probing of DEAD-box proteins as general RNA chaperonesR01GM070456 · NIGMS · UNIVERSITY OF TEXAS AUSTIN · PI RUSSELL, RICK · 2004 to 2017
$3.6M
Single molecule fluorescence detection of fragile X mutationsR41HD061163 · NICHD · AMBION DIAGNOSTICS, INC. · PI CHEN, LIANGJING CHEN · 2009 to 2009
$324k
NICHD NIH HHS R41 HD061163NIGMS NIH HHS R01 GM070456
6 · The paper itself

Abstract

Fragile X syndrome is the leading cause of inherited mental impairment and is associated with expansions of CGG repeats within the FMR1 gene. To detect expanded CGG repeats, we developed a dual-mode single-molecule fluorescence assay that allows acquisition of two parallel, independent measures of repeat number based on (1) the number of Cy3-labeled probes bound to the repeat region and (2) the physical length of the electric field-linearized repeat region, obtained from the relative position of a single Cy5 dye near the end of the repeat region. Using target strands derived from cell-line DNA with defined numbers of CGG repeats, we show that this assay can rapidly and simultaneously measure the repeats of a collection of individual sample strands within a single field of view. With a low occurrence of false positives, the assay differentiated normal CGG repeat lengths (CGG( N ), N = 23) and expanded CGG repeat lengths (CGG( N ), N = 118), representing a premutation disease state. Further, mixtures of these DNAs gave results that correlated with their relative populations. This strategy may be useful for identifying heterozygosity or for screening collections of individuals, and it is readily adaptable for screening other repeat disorders.

Indexed as

Trinucleotide Repeat ExpansionDNAFluorescenceFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeHeterozygoteHumansMicroscopy, FluorescenceMutationDNAFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1

Identifiers

PMID22311273
PMCPMC3398218
OpenAlexW2140328149

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.